scholarly journals Screening and Brief Intervention

Author(s):  
Michael I. Fingerhood

Screening and brief interventions for alcohol and other drugs are recommended by many expert guidelines. This is often followed by referral to treatment for those with a moderate–severe substance use disorder (SBIRT). Screening begins with asking about alcohol and other drug use; a number of instruments can help with this process. Brief intervention is a motivational process of assessing drug use, giving feedback, setting goals, arriving at a strategy for change, and providing a plan for follow-up. Research on SBIRT has yielded mixed results, with some evidence of efficacy, particularly for nondependent at-risk drinkers. Assessing an individual’s stage of change can help inform the approach to helping initiate recovery. Engaging and building rapport helps promote change by offering hope and encouragement, as well as treatment options. Relapse is a time for both patient and clinician to learn from mistakes and to correct them by strengthening treatment. Drug testing has limited utility for screening in unselected patient populations, but it can be useful in certain clinical situations and for monitoring individuals in treatment.

2018 ◽  
Vol 71 (suppl 5) ◽  
pp. 2258-2263 ◽  
Author(s):  
Ângela Maria Mendes Abreu ◽  
Rafael Tavares Jomar ◽  
Gunnar Glauco de Cunto Taets ◽  
Maria Helena do Nascimento Souza ◽  
Daiane Belisário Fernandes

ABSTRACT Objective: to identify the lifetime use of alcohol and other drugs among users of the Family Health Strategy and apply Brief Intervention to problems related to the use of these substances. Method: a descriptive cross-sectional study where 1,031 users of the Family Health Strategy of the city of Rio de Janeiro answered a form with socio-demographic information and the Alcohol, Smoking and Substance Involvement Screening Test. Statistical analysis with simple frequency distribution was performed. Results: the most commonly used drugs in lifetime were alcohol and tobacco; among the illegal drugs, marijuana, hypnotics and cocaine/crack stood out. Those who received most Brief Intervention were users of tobacco, hypnotics, marijuana, cocaine/crack and alcohol. Conclusion: it is important to detect early problems associated with the use of alcohol and other drugs in Primary Care, since it has the promotion/protection of health and the prevention of diseases as priority health practices.


2015 ◽  
Vol 10 (S2) ◽  
Author(s):  
Richard Saitz ◽  
Seville M Meli ◽  
Tibor P Palfai ◽  
Debbie Cheng ◽  
Daniel P Alford ◽  
...  

2014 ◽  
Vol 140 ◽  
pp. e192
Author(s):  
Richard Saitz ◽  
T.P. Palfai ◽  
D. Cheng ◽  
D.P. Alford ◽  
J.A. Bernstein ◽  
...  

2015 ◽  
Vol 156 ◽  
pp. e149-e150
Author(s):  
Seville Meli ◽  
Tibor Palfai ◽  
Debbie M. Cheng ◽  
D. Alford ◽  
Judith Bernstein ◽  
...  

2015 ◽  
Vol 156 ◽  
pp. e111-e112
Author(s):  
Theresa W. Kim ◽  
Judith Bernstein ◽  
Debbie M. Cheng ◽  
Jeffrey Samet ◽  
Christine Lloyd-Travaglini ◽  
...  

2010 ◽  
Vol 4 (3) ◽  
pp. 131-136 ◽  
Author(s):  
Leah E. Squires ◽  
Daniel P. Alford ◽  
Judith Bernstein ◽  
Tibor Palfai ◽  
Richard Saitz

2021 ◽  
pp. 000313482110241
Author(s):  
Rahul Tuli ◽  
Stephanie Anne Romero ◽  
Cesar Figueroa ◽  
Erika Tay ◽  
Soheil Saadat ◽  
...  

Introduction Drug and alcohol consumption are often associated with trauma-related injuries. Various studies have been conducted which have shown the benefits of screening and brief intervention (SBI) tools for alcohol consumption. Despite their success, there are few SBI tools utilized for substance use and minimal reports of computerized versions. We hypothesized that a computerized SBI tool for drug use would be effective at identifying patients at risk of substance abuse in a trauma setting. Methods This was a prospective evaluation of a computerized alcohol and drug screening and brief intervention survey derived from the National Institute on Drug Abuse. The survey was given to all eligible trauma patients at UCI’s Level 1 trauma facility between February 2019 and March 2020. Based on self-reported answers, a substance involvement (SI) score was generated which classified a patient’s drug abuse risk as none (0), low (1-3), moderate (4-26), or high (27+). Statistical tests were then used to examine associations between demographic variables and risk categorization. Results A total of 1801 patients completed the entire survey. Of those, 346 (19.3%) patients reported use of illicit drugs: 10 for non-medical prescription use (.6%), 308 (17.1%) for non-prescription drug use, and 28 (1.6%) for both. Secondary analysis revealed a greater number of males were eligible for further SI assessment (25.1% vs 11.0%, P < .001). Of those, a greater proportion of men were classified as moderate/high risk (81.6% vs 61.5%, P < .001). Further breakdown revealed a greater proportion of patients ≤25 years old reported use of drugs compared to >85 years old (37.0% vs .5%, P < .001). In contrast to the self-reported data, there was an overall positive rate of toxicology of 48.51%. Conclusion The analysis shows that the electronic survey identifies patients at risk of drug abuse, allowing for real-time intervention. Furthermore, it is granular enough to specify at-risk groups. However, a lower self-reported rate, as expected, was elucidated. Further studies to evaluate for improved screening and targeted intervention are warranted.


Sign in / Sign up

Export Citation Format

Share Document